Searchable abstracts of presentations at key conferences in endocrinology

ea0098p5 | Population Science | NANETS2023

Higher serotonin levels from ileum neuroendocrine tumors are associated with mesenteric mass progression

Yogo Akitada , Paciorek Alan , Moon Farhan , Bergsland Emily K. , Alseidi Adnan , Adam Mohamed , Maker Ajay , Corvera Carlos , Hirose Kenzo , Nakakura Eric K.

Background: Serotonin produced by ileum neuroendocrine tumors (i-NETs) promotes development of the mesenteric mass (MM) associated with lymph node metastases. We previously reported that more extensive MM progression along the superior mesenteric vessels predicts a lower rate of complete surgical resection. In this study, we hypothesized that tumoral serotonin production is associated not only with the development of MM but also its progression, and we examined serotonin level...

ea0098p6 | Population Science | NANETS2023

The use of antidepressants is associated with mesenteric mass formation of ileum neuroendocrine tumors

Yogo Akitada , Paciorek Alan , Moon Farhan , Bergsland Emily K. , Alseidi Adnan , Adam Mohamed , Maker Ajay , Corvera Carlos , Hirose Kenzo , Nakakura Eric K.

Background: Serotonin production by ileum neuroendocrine tumors (i-NETs) is considered a critical mediator of the fibrotic reaction in mesenteric mass (MM)/ lymph node metastasis. Antidepressants modify serotonin dynamics: however, their role in MM formation is uncertain. We hypothesized that histories of antidepressant use affect MM formation. This study examined the correlation between antidepressant use and MM formation.Methods: One hundred eighty-two...

ea0029p297 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Effect of triiodothyronine and angiotensin-II on expression of (pro)renin receptor in the human erythroid cell line, YN-1

Nishiyama H. , Kaneko K. , Ohba K. , Yoshioka T. , Shimizu T. , Hirose T. , Totsune K. , Takahashi K.

The renin–angiotensin system is known to enhance erythropoiesis. (Pro)renin receptor ((P)RR), a specific receptor for renin and prorenin, has recently been identified. We have recently shown expression of (P)RR in a human erythroid cell line, YN-1. It is known that triiodothyronine (T3) and angiotensin-II (A-II) stimulate proliferation of erythroid cells. The aim of the present study is to clarify effects of T3 and A-II on expression of (P)RR in the ...

ea0029p1245 | Obesity | ICEECE2012

Measurement of serum high-molecular-weight (HMW) adiponectin level using recently-developed chemiluminescence enzyme immunoassay (CLEIA) at health check-up

Hirose H. , Kawabe H. , Saito I.

Aim: A chemiluminescence enzyme immunoassay (CLEIA) for high-molecular-weight adiponectin (HMW-ADPN) was recently developed, and has been shown to be faster, more accurate and less expensive than conventional ELISA. In this study, we investigated the relationships between metabolic parameters and the HMW-ADPN level measured by CLEIA in a health check-up setting.Methods: Informed consent was obtained from 1036 male and 416 female Japanese, 40 to 71 years ...

ea0077op5.3 | Bone and Calcium | SFEBES2021

Vitamin D deficiency is highly prevalent among patients who died from COVID-19 in the North-East of England.

Motohashi Kenzo , Ann Tee Su , Echevarria Carlos , Burns Graham , Quinton Richard

Background: Vitamin D deficiency (VDD) has been implicated in the pathophysiology of respiratory infections, including Coronavirus Disease 2019 (COVID-19). We assessed vitamin D levels of patients who died from COVID-19 during or following admission to Newcastle-upon-Tyne Hospitals.Methods: We performed a retrospective survey of electronic patient records for 2,355 patients admitted to our institution between 04/02/2020 and 19/01/2021, who had a positive...

ea0050p206 | Diabetes and Cardiovascular | SFEBES2017

The impact of a dedicated metabolic hepatology clinic for the treatment of non-alcoholic fatty liver disease

Motohashi Kenzo , Moolla Ahmad , Marjot Tom , Ainsworth Mark , Tomlinson Jeremy , Cobbold Jeremy

Introduction: Non-Alcoholic Fatty Liver Disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is tightly associated with insulin resistance and type 2 diabetes (T2DM), both risk factors for disease progression, liver failure and cardiovascular complications. A multidisciplinary approach involving hepatologists and diabetologists working alongside allied health professionals is thus advocated for the management of NAFLD. Interv...

ea0050p206 | Diabetes and Cardiovascular | SFEBES2017

The impact of a dedicated metabolic hepatology clinic for the treatment of non-alcoholic fatty liver disease

Motohashi Kenzo , Moolla Ahmad , Marjot Tom , Ainsworth Mark , Tomlinson Jeremy , Cobbold Jeremy

Introduction: Non-Alcoholic Fatty Liver Disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is tightly associated with insulin resistance and type 2 diabetes (T2DM), both risk factors for disease progression, liver failure and cardiovascular complications. A multidisciplinary approach involving hepatologists and diabetologists working alongside allied health professionals is thus advocated for the management of NAFLD. Interv...

ea0056p306 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

A multi-disciplinary approach to the management of NAFLD improves both liver and metabolic health and is cost effective

Moolla Ahmad , Motohashi Kenzo , Shard Amelia , Marjot Tom , Ainsworth Mark , Tomlinson Jeremy , Cobbold Jeremy

Introduction: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is tightly associated with type 2 diabetes (T2DM), the principal risk factor for disease progression, liver failure and cardiovascular complications. At present there are no licensed therapies and management aims to optimise metabolic risk factors through weight loss, and pharmacological interventions for diabetes and cardiovascular disease. A multidisciplinary approa...